Currenc Group, Inc. (CURR)

USD 1.52

(-6.75%)

Net Debt Summary of Currenc Group, Inc.

  • Currenc Group, Inc.'s latest annual net debt in 2023 was -16.57 Million USD , down -632.38% from previous year.
  • Currenc Group, Inc.'s latest quarterly net debt in 2024 Q2 was 622.29 Thousand USD , up 104.0% from previous quarter.
  • Currenc Group, Inc. reported annual net debt of 3.11 Million USD in 2022, down -77.6% from previous year.
  • Currenc Group, Inc. reported annual net debt of 13.89 Million USD in 2021, down -4.83% from previous year.
  • Currenc Group, Inc. reported quarterly net debt of -15.56 Million USD for 2024 Q1, down 0.0% from previous quarter.
  • Currenc Group, Inc. reported quarterly net debt of -16.57 Million USD for 2023 FY, down -632.38% from previous quarter.

Annual Net Debt Chart of Currenc Group, Inc. (2023 - 2014)

Historical Annual Net Debt of Currenc Group, Inc. (2023 - 2014)

Year Net Debt Net Debt Growth
2023 -16.57 Million USD -632.38%
2022 3.11 Million USD -77.6%
2021 13.89 Million USD -4.83%
2020 14.6 Million USD 541.68%
2019 -3.3 Million USD -157.33%
2018 5.76 Million USD 151.41%
2017 2.29 Million USD 326.33%
2016 -1.01 Million USD -125.63%
2015 3.95 Million USD 61.62%
2014 2.44 Million USD 0.0%

Peer Net Debt Comparison of Currenc Group, Inc.

Name Net Debt Net Debt Difference
ANI Pharmaceuticals, Inc. 94.2 Million USD 117.592%
Aquestive Therapeutics, Inc. 74.95 Million USD 122.112%
Collegium Pharmaceutical, Inc. 435.33 Million USD 103.807%
Cosmos Health Inc. 8.59 Million USD 292.918%
Dynavax Technologies Corporation 106.63 Million USD 115.542%
Intra-Cellular Therapies, Inc. -130.82 Million USD 87.332%
Pacira BioSciences, Inc. 432.74 Million USD 103.83%
Sunshine Biopharma, Inc. -15.63 Million USD -6.003%
Sunshine Biopharma, Inc. -15.63 Million USD -6.003%
SCYNEXIS, Inc. -19.35 Million USD 14.351%
Safety Shot Inc -2.28 Million USD -625.499%
China SXT Pharmaceuticals, Inc. -9.42 Million USD -75.754%
Alpha Teknova, Inc. 1.97 Million USD 939.571%
Bright Green Corporation 1.84 Million USD 999.87%
Esperion Therapeutics, Inc. 458.69 Million USD 103.613%
Embecta Corp. 1.31 Billion USD 101.263%
PainReform Ltd. -7.95 Million USD -108.467%
Journey Medical Corporation -9.7 Million USD -70.699%
Procaps Group, S.A. 242.93 Million USD 106.822%
Theratechnologies Inc. 24.87 Million USD 166.636%
Harrow Health, Inc. 116.41 Million USD 114.236%
Sonoma Pharmaceuticals, Inc. -2.52 Million USD -557.664%
Biofrontera Inc. 4.05 Million USD 508.608%
DURECT Corporation -7.65 Million USD -116.529%
Supernus Pharmaceuticals, Inc. -33.52 Million USD 50.568%
Cronos Group Inc. -663.32 Million USD 97.502%
OptiNose, Inc. 58.06 Million USD 128.542%
Ironwood Pharmaceuticals, Inc. 623.38 Million USD 102.659%
Kala Pharmaceuticals, Inc. -14.57 Million USD -13.733%
RedHill Biopharma Ltd. -5.18 Million USD -219.572%
Organogenesis Holdings Inc. 15.01 Million USD 210.392%
Guardion Health Sciences, Inc. -6.35 Million USD -160.598%
Cumberland Pharmaceuticals Inc. 106.85 Thousand USD 15609.339%
Radius Health, Inc. 359.28 Million USD 104.613%
Universe Pharmaceuticals INC 197.2 Thousand USD 8503.838%
ProPhase Labs, Inc. 19.23 Million USD 186.179%
Phibro Animal Health Corporation 454.84 Million USD 103.644%
Procaps Group S.A. 242.93 Million USD 106.822%
Alvotech 1.06 Billion USD 101.557%
TherapeuticsMD, Inc. 3.67 Million USD 550.602%
Viatris Inc. 17.13 Billion USD 100.097%
Rockwell Medical, Inc. 4.45 Million USD 471.928%
Aytu BioPharma, Inc. -4.87 Million USD -239.822%
SIGA Technologies, Inc. -148.68 Million USD 88.853%
Tilray Brands, Inc. 158.97 Million USD 110.425%
Lifecore Biomedical, Inc. 121.89 Million USD 113.596%
Shineco, Inc. 29.29 Million USD 156.582%
PetIQ, Inc. 351.93 Million USD 104.709%
Regencell Bioscience Holdings Limited -2.9 Million USD -471.206%
Incannex Healthcare Limited -5.48 Million USD -202.154%
Neurocrine Biosciences, Inc. 177.3 Million USD 109.348%
Alimera Sciences, Inc. 55.3 Million USD 129.965%
Silver Spike Investment Corp. -32.61 Million USD 49.18%
Assertio Holdings, Inc. -32.52 Million USD 49.051%
Shuttle Pharmaceuticals Holdings, Inc. -1.48 Million USD -1013.245%
Petros Pharmaceuticals, Inc. -5.06 Million USD -227.507%
Clever Leaves Holdings Inc. -4.81 Million USD -244.269%
Cyclo Therapeutics, Inc. -8.21 Million USD -101.78%
Avadel Pharmaceuticals plc 4.21 Million USD 493.007%
Hempacco Co., Inc. 13.61 Million USD 221.73%
Talphera, Inc. -5.72 Million USD -189.689%
Alvotech 1.06 Billion USD 101.557%
Eagle Pharmaceuticals, Inc. 7.14 Million USD 331.954%
Lantheus Holdings, Inc. -96.71 Million USD 82.863%
Kamada Ltd. -46.43 Million USD 64.306%
Indivior PLC -33.95 Million USD 51.187%
Evoke Pharma, Inc. 260.57 Thousand USD 6460.237%
Flora Growth Corp. -713 Thousand USD -2224.421%
Cyclo Therapeutics, Inc. -8.21 Million USD -101.78%
Evolus, Inc. 63.7 Million USD 126.014%
HUTCHMED (China) Limited -197.45 Million USD 91.607%
Amphastar Pharmaceuticals, Inc. 479.11 Million USD 103.459%
Akanda Corp. 3.9 Million USD 524.417%